MDLN · Medline Inc.
$38.75
+2.04% last session
End-of-day data · updated 2026-07-28
Market cap
$71B
Enterprise value
$51B
Trailing P/E
34.8
Forward P/E
23.8
Dividend yield
—
Beta
—
Avg volume
10M
Employees
45K
2D change
—
5D change
5.50%
10D change
-0.23%
30D change
2.14%
60D change
8.59%
MTD change
-4.86%
YTD change
-5.48%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — MDLN
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-06-03
Latest call per bank · past 12 months
Barclays
Overweight$45.00
+16.1% vs priceCitigroup
Buy$55.00
+41.9% vs priceJP Morgan
Overweight$53.00
+36.8% vs priceMorgan Stanley
Overweight$52.00
+34.2% vs priceWells Fargo
Equal-Weight$47.00
+21.3% vs priceUBS
Buy$57.00
+47.1% vs priceRBC Capital
Outperform$53.00
+36.8% vs priceGoldman Sachs
Buy$49.00
+26.5% vs priceDeutsche Bank
Hold$40.00
+3.2% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-06-03 | Baird | Maintains | Outperform | $57.00 → $45.00 |
| 2026-06-01 | Barclays | Maintains | Overweight | $50.00 → $45.00 |
| 2026-05-14 | BNP Paribas | Maintains | Neutral | $49.00 → $40.00 |
| 2026-05-13 | Tigress Financial | Maintains | Buy | $60.00 → $62.00 |
| 2026-05-07 | Citigroup | Maintains | Buy | $60.00 → $55.00 |
| 2026-05-07 | Bernstein | Maintains | Outperform | $56.00 → $54.00 |
| 2026-05-07 | BTIG | Reiterates | Buy | $55.00 |
| 2026-03-10 | JP Morgan | Maintains | Overweight | $50.00 → $53.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-28
- RSI (14): RSI is 55 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 7.2% above the 50-day MA ($37.80).
- MACD (12,26,9): MACD histogram is negative (-0.17) — short-term momentum is fading.
- 52-week range: Price sits between the 52-week low ($33.19) and high ($49.99).
MDLN Price Chart
Loading chart for MDLN…
Fundamentals
About Medline Inc.
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.
More in Medical Instruments & Supplies
ISRG
Intuitive Surgical, Inc.
$128B -37.0% YTD
ALC
Alcon Inc.
$33B -14.2% YTD
RMD
ResMed Inc.
$29B -15.2% YTD
WST
West Pharmaceutical Services, I
$23B 20.6% YTD
SOLV
Solventum Corporation
$14B 1.6% YTD
ALGN
Align Technology, Inc.
$12B 7.6% YTD
BAX
Baxter International Inc.
$12B 22.3% YTD
ATR
AptarGroup, Inc.
$9B 10.2% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.